Semaglutide 5mg

Most patients begin noticing reduced appetite within the first 1-2 weeks. Meaningful weight loss typically occurs within 4-8 weeks of reaching therapeutic doses. Individual results vary based on adherence, diet, and lifestyle factors.

The most common side effects are gastrointestinal in nature: nausea, vomiting, diarrhea, and constipation. These typically occur during dose escalation and often improve with continued use. Starting at a low dose and gradually increasing helps minimize these effects.

Semaglutide is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It should not be used during pregnancy or breastfeeding. Your medical provider will review your complete health history to determine eligibility.

Our semaglutide is compounded in FDA-registered 503B outsourcing facilities using the same active pharmaceutical ingredient. Each batch is tested for purity, potency, and sterility. The key advantage is accessibility and cost-effectiveness while maintaining pharmaceutical-grade quality standards.

Yes, you can pause or cancel your subscription at any time through your patient portal or by contacting our support team. We recommend discussing any treatment changes with your provider to ensure a safe and effective transition.